Longevity India Conference explores translational research and clinical perspective

The second day of the ongoing Longevity India Conference 2025 focused on translational research and clinical perspectives in longevity science. Hosted at the Indian Institute of Science, Bengaluru, the day featured engaging discussions on cutting-edge innovations, diagnostics, health optimisation frameworks, and emerging technologies in longevity science.

Matt Kaeberlein, CEO of Optispan, emphasised the role of predictive analytics and AI in transforming aging research, highlighting their potential to measure, understand, and eventually control the biological processes that define longevity.

Deepak Saini, a professor at IISc, said, “Aging trajectories are highly personal. The “one-size-fits-all” approach will not address the demands of aging. Multidisciplinary data analytics will lead to the emergence of new ways to examine one’s health, which then can alter health span.”